Mission Critical: Bringing drug discount stakeholders together so patients win


It’s a make-or-break moment for drug discount programs in the U.S.: Program costs are rising, while growing noncompliance figures create operational burdens for all stakeholders.

In our 2023 annual report, we explore:

  • How a collaboration breakdown among stakeholders created drug discount dysfunction

  • Why the solution to systemic obstacles must start by building trust and bringing every stakeholder to the table

  • How revolutionary, tech-enabled solutions that engage stakeholders equally can provide transparency to the true scale of misapplied discounts

Fill out the form below to download the report now.

By submitting this form, I agree that Kalderos may contact me at the email address or phone number above to tell me about its services.